Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1986
Adrenal steroid responses to continuous intravenous adrenocorticotropin infusion compared to bolus injection in normal volunteersA K Munabi, P Feuillan, R C Staton, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Pharmacokinetics of VP16-213 given by different administration methodsM D'Incalci, P Farina, C Sessa, et al.
Biopharmaceutics & Drug Disposition|August 1, 1995
Pharmacokinetics of reboxetine in healthy volunteers. Single oral doses, linearity and plasma protein bindingD M Edwards, C Pellizzoni, H P Breuel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
A phase I and pharmacokinetic study of tallimustine [PNU 152241 (FCE 24517)] in patients with advanced cancerG R Weiss, I Poggesi, M Rocchetti, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
Pharmacological profile of the novel inotropic agent (E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride (PST2744)R Micheletti, G G Mattera, M Rocchetti, et al.
Anti-Cancer Drugs|May 4, 2001
Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxelJ M Meerum Terwogt, W W ten Bokkel Huinink, J H Schellens, et al.
Psychiatry Journal|June 18, 2016
Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPSP Fusar-Poli, M Cappucciati, G Rutigliano, et al.
Acta Physiologica (Oxford, England)|May 15, 2024
Striatin knock out induces a gain of function of INa and impaired Ca2+ handling in mESC-derived cardiomyocytesP Benzoni, M Arici, F Giannetti, et al.
Pageof 18